Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 704,427 650,295 503,841 463,131 403,511 435,624 - -
Change - -7.68% -22.52% -8.08% -12.87% 7.96% - -
Enterprise Value (EV) 1 596,011 546,554 424,992 398,232 333,575 373,212 365,600 359,828
Change - -8.3% -22.24% -6.3% -16.24% 11.88% -2.04% -1.58%
P/E 35.8x 34.8x 25.3x 46x 110x 42.1x 32.4x 26.2x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.08x 2.02x 1.95x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1.1x 1.1x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 2.53x 2.43x 2.34x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.17x 2.04x 1.93x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 17x 13.6x 11.6x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 29.2x 21.1x 16.9x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 25.9x 24x 21x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 3.85% 4.16% 4.76%
Dividend per Share 2 83 90 101 102 104 106 109.5 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.81% 1.87% 1.95%
EPS 2 252.4 259.6 268.2 135.4 49.19 139.1 181.1 223.7
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 76.2% 60.5% 51.1%
Net sales 1 155,252 166,258 173,455 165,600 165,742 172,061 179,446 186,503
EBITDA 1 30,900 32,027 31,837 32,800 23,600 22,012 26,890 31,112
EBIT 1 26,065 26,669 25,780 24,860 14,923 12,780 17,350 21,293
Net income 1 19,715 20,022 20,338 10,067 3,656 10,438 13,554 16,348
Net Debt 1 -108,416 -103,741 -78,849 -64,899 -69,936 -62,413 -70,024 -75,796
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 5,860.00 5,860.00 5,860.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 2/4/22 A 2/14/23 A 2/9/24 A 2/10/25 A 2/10/26 A - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
21.68x4.14x15.14x2.98% 343B
18.21x2.71x11.94x3.55% 133B
23.86x3.58x15.05x2.42% 69.94B
40.38x6.48x28.13x2.31% 47.65B
31.66x2.51x13.91x1.7% 33.96B
18.82x2.66x11.08x4.72% 34.32B
22.57x1.65x10.53x2.24% 20.28B
19.79x1.26x8.23x1.33% 18.79B
15.32x1.48x8.33x3.47% 18.24B
Average 23.59x 2.94x 13.59x 2.75% 79.9B
Weighted average by Cap. 22.64x 3.61x 14.66x 2.96%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. KOY Stock
  5. Valuation Kobayashi Pharmaceutical Co., Ltd.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!